Novartis has added another non-alcoholic steatohepatitis (NASH) drug candidate to its pipeline via an $80 million licensing deal with US biotech Pliant ... with obesity, diabetes and high ...

President Trump’s nominee to run the FDA secured the Senate HELP Committee’s backing. Elsewhere, Sutro cut jobs and a cell ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a limited duration ...

New Tech for Managing Type 1 Diabetes Is Effective for Older Adults Mar. 11, 2025 — New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older ...

Type 2 diabetes can cause complications if not managed properly. These include nerve damage, kidney disease, and stroke. You can help prevent these by having regular checkups with your doctor and ...

"It is a challenging disease and a lot of people want better treatments." Recently, US-based and Nasdaq-listed Pliant Pharmaceuticals announced it had discontinued its BEACON-IPF Phase 2b trial ...

Diabetes describes a group of metabolic diseases characterized by high blood sugar levels. Diabetes can be caused by the pancreas not producing insulin (type 1 diabetes) or by insulin resistance ...

When your blood sugar levels fall within the recommended ranges, it’s a sign your diabetes treatment and management plan is working. You and your doctor can determine your exact blood sugar targets.

A pliant media amplifies the noise, creating cacophony.” ‘Buckle up, there’s more to come’ The Constitution and the identity of the man that entrenched it – the first President of the ...